ast
alt
catalyz
transfer
group
alanin
aspart
acid
acid
respect
ast
found
liver
cardiac
skelet
muscl
kidney
brain
pancrea
lung
leukocyt
erythrocyt
alt
exist
mainli
liver
exist
low
concentr
tissu
recent
isoform
clone
separ
chromosom
chr
classic
alt
chr
high
homolog
ident
protein
level
isoenzym
wider
organ
distribut
includ
skelet
muscl
adipos
tissu
date
howev
clinic
signific
diagnosi
liver
diseas
remain
defin
aminotransferas
activ
may
measur
sever
method
chromatographi
spectrophotometri
fluorimetri
colorimetri
although
assay
result
may
differ
slightli
accord
method
use
high
degre
correl
common
method
name
colorimetri
spectrophotometri
particularli
near
normal
rang
recent
renew
attent
constitut
normal
rang
serum
activ
aminotransferas
particularli
alt
tradit
level
around
consid
upper
limit
normal
base
mean
standard
deviat
calcul
appar
healthi
refer
subject
increas
consensu
convent
normal
rang
may
set
high
refer
subject
presum
healthi
may
includ
individu
asymptomat
liver
diseas
nonalcohol
fatti
liver
diseas
chronic
hepat
c
stringent
criteria
appli
exclud
subject
high
probabl
liver
diseas
upper
limit
normal
rang
becom
consider
lower
prati
colleagu
analyz
sampl
blood
donor
care
select
exclud
risk
liver
diseas
use
criteria
normal
bodi
mass
index
bmi
normal
cholesterol
triglycerid
glucos
level
potenti
hepatotox
medic
upper
limit
normal
alt
studi
determin
ul
men
ul
women
although
updat
normal
valu
frequent
cite
one
may
note
way
upper
limit
normal
set
particular
studi
differ
usual
convent
wherea
laboratori
normal
rang
taken
middl
ie
percentil
popul
prati
colleagu
chose
take
lower
percentil
normal
author
believ
normal
rang
propos
studi
set
low
other
taken
differ
approach
hypothes
normal
alt
defin
cross
section
popul
may
equat
absenc
diseas
word
normal
alt
necessarili
healthi
alt
larg
populationbas
studi
south
korea
serum
alt
activ
measur
baselin
correl
subsequ
mortal
particular
compar
men
alt
less
iul
alt
iul
increas
liver
mortal
alt
iul
increas
mortal
author
also
evalu
alt
ast
activ
predictor
futur
mortal
use
populationbas
data
olmst
counti
ast
alt
result
given
year
correl
subsequ
allcaus
mortal
similar
data
kim
colleagu
posit
correl
standard
mortal
ratio
aminotransferas
result
increas
mortal
could
discern
aminotransferas
valu
less
upper
limit
normal
set
laboratori
time
anoth
aspect
serum
aminotransferas
activ
clinician
must
awar
variabl
well
within
individu
subject
sever
factor
age
sex
bmi
influenc
activ
subject
without
known
liver
diseas
addit
earli
studi
friedman
show
alt
elev
intermitt
persist
month
observ
one
limit
studi
includ
larg
proport
patient
consum
alcohol
regularli
make
possibl
fluctuat
alt
simpli
result
variabl
subsequ
studi
lazo
colleagu
investig
variabl
liver
enzym
use
sampl
nation
health
nutrit
examin
survey
nearli
survey
respond
biochem
assess
separ
mean
day
initi
test
abnorm
ast
alt
respect
use
normal
rang
defin
laboratori
initi
elev
result
ast
alt
reclassifi
normal
followup
test
expect
mildli
elev
ast
alt
like
normal
repeat
test
peopl
transit
abnorm
normal
initi
elev
within
time
normal
rang
anoth
element
intraindividu
variabl
aminotransferas
diurnal
variat
accord
cordoba
colleagu
alt
level
lowest
night
highest
afternoon
serum
aminotransferas
activ
may
elev
result
varieti
caus
although
commonli
deriv
hepatobiliari
disord
increas
aminotransferas
level
may
seen
extrahepat
condit
tabl
summar
potenti
caus
abnorm
aminotransferas
nonalcohol
fatti
liver
diseas
nafld
thought
common
caus
abnorm
liver
enzym
studi
magnet
reson
spectroscopi
use
measur
liver
triglycerid
content
preval
nafld
unit
state
estim
nafld
may
may
increas
aminotransferas
level
mild
elev
aminotransferas
level
may
find
nafld
patient
earli
nafld
alt
usual
higher
ast
astalt
nafld
advanc
caus
liver
fibrosi
astalt
ratio
revers
degre
alt
patient
cirrhosi
nafld
may
normal
trend
reflect
nafld
fibrosi
score
age
year
bmi
kgm
impair
fast
glucosediabet
ye
astalt
ratio
platelet
l
albumin
gdl
may
use
estim
liver
fibrosi
alcohol
liver
diseas
ald
common
caus
liverrel
mortal
alcoholrel
mortal
unit
state
larg
degre
variabl
pattern
amount
alcohol
consumpt
seen
patient
ald
ald
probabl
underdiagnos
common
form
alcohol
fatti
liver
asymptomat
sever
form
ald
includ
alcohol
hepat
alcohol
cirrhosi
depend
sever
ongo
liver
damag
aminotransferas
level
rang
normal
time
upper
limit
normal
high
ast
alt
ratio
thought
indic
ald
ratio
ald
highli
like
wherea
ratio
greater
strongli
suggest
hand
astalt
ratio
less
necessarili
exclud
ald
even
ratio
less
may
seen
patient
signific
intak
alcohol
may
suggest
alcohol
steatosi
rather
seriou
form
ald
import
clinician
keep
mind
possibl
concomit
caus
liver
diseas
patient
alcohol
abus
ald
patient
polysubst
abus
hepat
c
viru
infect
commonli
coexist
ald
alcohol
may
also
potenti
hepatotox
drug
although
rare
necessari
establish
diagnosi
liver
biopsi
may
show
characterist
featur
includ
balloon
degener
hepatocyt
mallori
bodi
infiltr
polymorphonuclear
leukocyt
wide
rang
prescript
drug
may
caus
elev
liver
enzym
although
almost
medic
potenti
caus
elev
serum
aminotransferas
certain
antibiot
antivir
statin
hormon
agent
anesthet
antiseizur
medic
wellknown
exampl
hepatotox
drug
clinic
present
druginduc
liver
injuri
dili
variabl
rang
asymptomat
enzym
elev
acut
hepat
failur
dili
dose
depend
idiosyncrat
dose
independ
prototyp
exampl
former
acetaminophen
although
acetaminophen
overdos
recogn
common
caus
acut
liver
failur
recent
random
trial
show
use
within
maximum
allow
dose
also
associ
high
incid
alt
elev
clinician
must
awar
hepatotox
dosedepend
hepatotoxin
may
develop
within
recommend
maximum
daili
dose
depend
genet
predisposit
medic
sometim
food
intak
may
affect
patient
abil
metabol
drug
eg
cytochrom
enzym
idiosyncrat
reaction
common
definit
unpredict
essenti
medic
caus
idiosyncrat
reaction
includ
overthecount
medic
ranitidin
latent
period
sever
month
onset
idiosyncrat
featur
occasion
dili
may
accompani
hypersensit
reaction
ie
fever
rash
eosinophilia
characterist
dili
make
diagnosi
sometim
difficult
care
histori
take
high
index
suspicion
need
diagnosi
liver
biopsi
limit
role
diagnosi
differenti
diagnosi
dili
histolog
featur
dili
often
nonspecif
distinguish
viral
immunemedi
injuri
care
exclus
diagnos
assess
respons
withdraw
suspect
drug
constitut
import
diagnost
therapeut
step
rechalleng
offend
drug
reserv
select
situat
wherebi
benefit
drug
outweigh
risk
potenti
sever
hepatotox
besid
medic
herbal
prepar
chemic
pesticid
metal
caus
hepatotox
illicit
drug
cocain
ecstasi
phencyclidin
pcp
angel
dust
gluesolv
anabol
steroid
also
known
hepatotox
detail
histori
clearli
crucial
patient
use
drug
may
reluct
reveal
exposur
histori
wherea
circumst
exposur
hepatotox
materi
may
inadvert
clinician
must
awar
excess
alcohol
use
drug
abus
often
coexist
thu
patient
histori
heavi
drink
ald
clinician
must
inquir
exposur
hepatotox
drug
awar
potenti
interact
alcohol
hepat
b
c
e
virus
may
caus
elev
aminotransferas
among
hepat
e
virus
caus
acut
infect
wherea
hepat
b
c
hepat
diagnos
detect
immunoglobulin
igm
antihepat
viru
hav
serum
diagnosi
hepat
b
viru
hbv
infect
usual
made
detect
hepat
b
surfac
antigen
hbsag
although
sometim
antihepat
b
core
antibodi
may
clue
diagnosi
hepat
viru
hdv
replic
host
hbv
infect
hdv
rna
revers
transcriptas
polymeras
chain
reaction
rtpcr
reliabl
test
igm
immunoglobulin
g
igg
antihdv
use
whose
sensit
less
hdv
rna
rtpcr
method
hepat
c
viru
hcv
infect
screen
antihcv
antibodi
confirm
hcv
rna
detect
diagnosi
hepat
e
viru
hev
antihev
antibodi
igmigg
may
use
howev
avail
test
hev
limit
unit
state
system
infect
virus
epsteinbarr
viru
ebv
cytomegaloviru
cmv
herp
simplex
viru
hsv
varicella
zoster
viru
vzv
sever
acut
respiratori
syndrom
sar
viru
may
caus
elev
aminotransferas
aminotransferas
elev
caus
ebv
usual
seen
conjunct
acut
mononucleosi
usual
selflimit
even
though
chronic
infect
possibl
similarli
immunecompet
host
cmv
infect
present
subclin
mild
symptomat
case
resolv
cmv
infect
seriou
immunecompromis
host
includ
patient
aid
solid
organ
recipi
dissemin
infect
may
caus
major
organ
damag
mortal
hsv
hepat
commonli
seen
neonat
pregnant
immunecompromis
patient
mani
case
present
fulmin
hepat
high
mortal
hemochromatosi
common
genet
diseas
caucasian
subject
persist
elev
aminotransferas
must
evalu
hemochromatosi
initi
diagnost
test
start
serum
ferritin
transferrin
satur
follow
hfe
genotyp
wilson
diseas
present
acut
liver
failur
well
chronic
liver
diseas
patient
unexplain
liver
diseas
especi
accompani
neurolog
psychiatr
manifest
atyp
autoimmun
nonalcohol
fatti
liver
diseas
must
consid
wilson
diseas
serum
ceruloplasmin
level
urin
copper
level
ophthalmolog
examin
kayserfleisch
ring
initi
test
diagnosi
defici
may
present
mildli
abnorm
liver
enzym
liver
cirrhosi
preval
genet
phenotyp
defici
estim
unit
state
prefer
screen
test
defici
phenotyp
rather
serum
level
sever
rare
metabolicgenet
liver
diseas
may
caus
elev
liver
enzym
includ
glycogen
storag
diseas
porphyria
tyrosinemia
urea
cycl
defect
cystic
fibrosi
mitochondri
liver
diseas
preval
autoimmun
hepat
per
million
caucasian
popul
northern
europ
north
america
presenc
autoantibodi
antinuclear
antismooth
muscl
antibodi
suggest
diagnosi
especi
elev
serum
level
gglobulin
present
score
system
propos
intern
autoimmun
hepat
group
may
use
diagnosi
primari
biliari
cirrhosi
pbc
primari
scleros
cholang
psc
repres
commonli
encount
form
cholestat
liver
diseas
character
elev
alkalin
phosphatas
rather
aminotransferas
evalu
elev
liver
enzym
uncommon
preval
per
person
pbc
per
person
psc
unit
state
liver
biopsi
may
necessari
diagnosi
patient
present
clinic
pictur
consist
pbc
posit
antimitochondri
antibodi
ama
diagnosi
psc
usual
made
cholangiographi
inflammatori
bowel
diseas
coexist
psc
patient
autoantibodi
perinuclear
antineutrophil
cytoplasm
antibodi
may
found
psc
patient
diagnost
util
limit
patient
featur
cholestat
liver
diseas
significantli
increas
aminotransferas
upper
limit
normal
overlap
syndrom
autoimmun
hepat
consid
secondari
scleros
cholang
share
cholangiograph
featur
psc
must
consid
differenti
diagnosi
buddchiari
syndrom
caus
obstruct
either
hepat
vein
inferior
vena
cava
result
acut
chronic
diseas
although
liver
enzym
may
strikingli
abnorm
jaundic
ascit
commonli
seen
doppler
ultrasound
sensit
screen
test
sinusodi
obstruct
syndrom
so
also
known
venoocclus
diseas
caus
endotheli
injuri
hepat
sinusoid
hepat
venul
typic
associ
bone
marrow
transplant
certain
chemotherapeut
agent
abdomin
radiat
so
suspect
clinic
featur
consist
jaundic
portal
vein
hypertens
abnorm
liver
enzym
transjugular
liver
biopsi
common
method
diagnosi
ischem
hepat
caus
hypoperfus
liver
present
extrem
high
aminotransferas
level
usual
ul
altlact
dehydrogenas
ratio
may
also
use
stay
case
diagnosi
rel
straightforward
base
clinic
set
aminotransferas
elev
certain
nonhepat
condit
obvious
ast
one
cardiac
enzym
whose
elev
seen
cardiac
condit
ischem
heart
diseas
congest
heart
failur
system
diseas
celiac
diseas
adren
insuffici
hyperthyroid
hypothyroid
may
associ
aminotransferas
elev
even
demonstr
concomit
liver
diseas
ast
alt
express
skelet
muscl
condit
associ
myocyt
damag
includ
primari
muscl
diseas
strenuou
exercis
may
increas
aminotransferas
patient
anorexia
nervosa
may
increas
liver
enzym
although
mechan
clear
isol
ast
elev
may
seen
macro
ast
macro
ast
macroenzym
high
molecular
mass
complex
plasma
enzym
immunoglubulin
protein
lead
reduc
plasma
clearanc
prolong
halflif
mayo
clinic
polyethyleneglycol
precipit
assay
develop
assay
macro
ast
alkalin
phosphatas
group
enzym
present
bone
liver
small
intestin
kidney
placenta
white
blood
cell
adult
common
clinic
situat
elev
serum
alkalin
phosphatas
activ
hepatobiliari
bone
diseas
pregnanc
isol
elev
alkalin
phosphatas
electrophoresi
use
fraction
isoenzym
suggest
sourc
ggt
present
kidney
pancrea
liver
spleen
heart
brain
semin
vesicl
one
clinic
use
serum
level
ggt
identifi
sourc
elev
alkalin
phosphatas
increas
bone
diseas
concomit
elev
alkalin
phosphatas
ggt
would
suggest
hepatobiliari
sourc
rather
skelet
sourc
common
use
ggt
patient
suspect
ald
ggt
induc
alcohol
ingest
medic
barbitur
phenytoin
may
also
increas
ggt
presum
mechan
recent
sever
report
correl
elev
ggt
increas
mortal
compar
refer
popul
normal
ggt
increas
ggt
higher
mortal
liver
diseas
cancer
diabet
well
cardiac
diseas
nonspecif
natur
serum
alkalin
phosphatas
ggt
result
greater
time
upper
limit
alkalin
phosphatas
greater
time
ggt
suggest
threshold
diagnost
workup
asymptomat
patient
care
histori
physic
examin
first
step
evalu
togeth
abdomin
ultrasonographi
magnet
reson
cholangiopancreatographi
mrcp
endoscop
retrograd
cholangiopancreatographi
ercp
endoscop
ultrasonographi
eu
well
serum
marker
antimitochondri
antibodi
use
evalu
hepatobiliari
system
liver
biopsi
use
although
diagnost
yield
may
vari
significantli
depend
clinic
set
decis
evalu
patient
abnorm
liver
enzym
individu
accord
patient
histori
clinic
data
even
though
frequent
abnorm
enzym
motiv
clinician
initi
evalu
liver
diseas
import
rememb
normal
liver
enzym
necessarili
rule
hepatobiliari
diseas
hand
mild
elev
liver
enzym
nonspecif
shown
studi
lazo
colleagu
case
abnorm
liver
enzym
end
reclassifi
normal
followup
initi
consult
includ
detail
histori
take
full
physic
examin
essenti
compon
evalu
reader
refer
avail
textbook
liver
diseas
base
clinic
data
avail
patient
abnorm
liver
enzym
may
categor
hepatocellular
versu
cholestat
former
character
elev
aminotransferas
wherea
latter
character
alkalin
phosphatas
obvious
condit
pattern
coexist
algorithm
may
help
guid
clinician
evalu
patient
abnorm
liver
enzym
shown
fig
common
clinic
scenario
hepatologist
asymptomat
patient
elev
liver
enzym
detect
incident
first
time
patient
initi
seen
elev
aminotransferas
monitor
clear
risk
factor
liver
diseas
liver
enzym
level
less
time
normal
liver
function
gaug
serum
bilirubin
albumin
prothrombin
time
preserv
patient
feel
well
condit
met
repeat
test
show
persist
abnorm
patient
acut
chronic
hepat
base
variou
caus
acut
chronic
hepat
subsequ
test
outlin
algorithm
often
liver
biopsi
consid
ultim
diagnost
test
abnorm
liver
enzym
howev
given
risk
bleed
complic
discomfortpain
expens
associ
liver
biopsi
clear
riskbenefit
calcul
need
one
perform
gener
clinician
must
convinc
histolog
inform
gain
biopsi
lead
key
therapeut
decis
possibl
otherwis
patient
present
cholestat
pattern
enzym
abnorm
ultrasonographi
repres
key
diagnost
step
may
detect
dilat
intrahepat
andor
extrahepat
bile
duct
mass
lesion
vascular
abnorm
evalu
mass
lesion
vascular
abnorm
rel
straightforward
biliari
diseas
suspect
diagnost
modal
mrcp
eu
ercp
may
use
locat
character
biliari
abnorm
light
appreci
risk
complic
ercp
without
sphincterotomi
mrcp
eu
increasingli
use
enhanc
pretest
diagnost
probabl
initi
ercp
cholangiographi
unrev
biliari
obstruct
may
level
small
bile
duct
eg
pbc
canalicular
eg
sepsi
dili
interpret
abnorm
liver
enzym
postop
set
uniqu
concentr
mani
procedur
medic
short
time
period
addit
presenc
liver
diseas
baselin
type
surgeri
choic
anesthet
agent
administr
blood
product
postsurg
analges
agent
affect
liver
potenti
result
abnorm
liver
enzym
preexist
liver
diseas
affect
risk
surgeri
anesthesia
patient
diminish
liver
function
addit
insult
liver
ischemia
druginduc
hepatotox
may
precipit
seriou
hepat
insuffici
howev
liver
abnorm
degre
asymptomat
patient
undergo
elect
surgeri
encount
frequent
routin
screen
liver
biochemistri
deem
costeffect
follow
discuss
address
potenti
caus
postop
liver
enzym
abnorm
underli
primari
liver
diseas
patient
may
baselin
ischem
liver
injuri
one
common
caus
elev
liver
enzym
surgeri
hepat
blood
flow
gener
decreas
gener
anesthet
agent
blood
loss
surgeri
obvious
contribut
hypoperfus
ischem
injuri
liver
type
surgeri
anesthesia
affect
blood
flow
liver
may
determin
ischem
injuri
exampl
increas
intraabdomin
pressur
carbon
dioxid
inflat
laparoscop
procedur
caus
compress
inferior
vena
cava
lead
decreas
cardiac
output
system
hypotens
transient
decreas
cardiac
output
cardiopulmonari
procedur
caus
liver
enzym
elev
ischemia
spinal
anesthesia
necessarili
safer
gener
anesthesia
case
ischem
liver
injuri
transient
requir
specif
therapi
import
howev
ensur
adequ
blood
flow
liver
postop
period
especi
cardiopulmonari
surgic
patient
system
perfus
may
compromis
volatil
anesthet
possibl
caus
elev
liver
enzym
halothan
may
caus
liver
damag
differ
way
first
caus
asymptomat
elev
liver
enzym
may
occur
mani
patient
undergo
halothan
anesthesia
elev
liver
enzym
mild
usual
improv
spontan
second
much
seriou
form
liver
damag
sever
acut
hepat
may
progress
fulmin
hepat
failur
syndrom
includ
system
evalu
elev
liver
enzym
symptom
high
fever
chill
nausea
vomit
eosinophilia
occur
typic
week
anesthesia
immunemedi
idiosyncrat
reaction
incid
fatal
case
modern
anesthet
enfluran
isofluran
desfluran
sevofluran
may
also
associ
idiosyncrat
reaction
much
lower
frequenc
halothan
propofol
use
sedat
induct
anesthesia
propofol
infus
syndrom
rare
fatal
occurr
present
acut
fatti
liver
togeth
acut
bradycardia
metabol
acidosi
inappropri
use
multidos
propofol
vial
recent
implic
pointsourc
epidem
hepat
b
c
viru
transmiss
transfusionmedi
viral
hepat
hepat
b
c
becom
extrem
rare
rare
residu
case
posttransfus
hepat
may
occur
result
falseneg
result
screen
test
least
theori
blood
donor
socal
window
period
neg
serolog
test
may
escap
detect
hepat
viru
infect
organ
transplant
set
nonhepat
virus
ebv
cmv
human
herp
viru
may
caus
hepat
reactiv
de
novo
infect
immunosuppress
patient
viral
infect
consid
incub
latent
period
use
clue
gaug
probabl
respons
given
clinic
present
recipi
organ
transplant
hepatotox
multitud
drug
use
set
also
consid
hyperbilirubinemia
jaundic
complic
increas
liver
enzym
may
indic
extent
liver
damag
sever
enough
decreas
liver
function
critic
level
case
particularli
coagulopathi
also
present
must
monitor
care
purpos
differenti
diagnosi
caus
postop
jaundic
mention
briefli
common
caus
postop
jaundic
indirect
hyperbilirubinemia
result
pigment
overload
eg
hematoma
conjunct
mild
liver
dysfunct
underli
gilbert
syndrom
may
lead
pronounc
hyperbilirubinemia
sever
postop
jaundic
may
follow
prolong
difficult
surgeri
postop
cours
complic
hypotens
hypoxemia
sepsi
system
inflammatori
respons
syndrom
import
differenti
diagnosi
particularli
jaundic
follow
biliari
tract
surgeri
obstruct
jaundic
case
clearli
requir
anatom
diagnosi
follow
endoscop
surgic
percutan
relief
obstruct
liver
enzym
repres
commonli
use
blood
test
physician
offic
although
still
uncertainti
exactli
defin
normal
cutoff
aminotransferas
remain
inexpens
sensit
test
screen
diagnosi
monitor
patient
varieti
liver
diseas
articl
outlin
author
approach
evalu
patient
abnorm
liver
enzym
mayo
clinic
patient
aminotransferasepredomin
pictur
care
histori
examin
small
number
laboratori
test
guid
subsequ
manag
patient
elev
alkalin
phosphatas
imag
evalu
becom
essenti
outlin
present
algorithm
see
fig
